Ekso Bionics to Report Second Quarter 2021 Financial Results on July 29, 2021
July 22 2021 - 8:00AM
Ekso Bionics Holdings, Inc. (Nasdaq: EKSO), an industry leader in
exoskeleton technology for medical and industrial use, today
announced that it will release financial and business results for
the second quarter 2021 after the close of trading on Thursday,
July 29, 2021. Management will host a conference call beginning at
1:30 p.m. PT, 4:30 p.m. ET to discuss the financial results and
recent business developments.
A live webcast of the event will be available in
the “Investors” section of the Company’s website at
www.eksobionics.com, or by clicking here. Investors interested in
listening to the conference call may do so by dialing 877-407-3036
for domestic callers or 201-378-4919 for international callers.
A replay of the call will be available for two
weeks by dialing 877-660-6853 for domestic callers or 201-612-7415
for international callers and using Conference ID: 13720543. The
webcast will also be available on the Company’s website for one
month following the completion of the call.
About Ekso
Bionics® Ekso Bionics® is a leading
developer of exoskeleton solutions that amplify human potential by
supporting or enhancing strength, endurance and mobility across
medical and industrial applications. Founded in 2005, Ekso Bionics
continues to build upon its industry-leading expertise to design
some of the most cutting-edge, innovative wearable robots available
on the market. Ekso Bionics is the only exoskeleton company to
offer technologies that range from helping those with paralysis to
stand up and walk, to enhancing human capabilities on job sites
across the globe. Ekso Bionics is headquartered in the San
Francisco Bay Area and is listed on the Nasdaq Capital Market under
the symbol “EKSO.” For more information, visit: www.eksobionics.com
or follow @EksoBionics on Twitter.
Investor Contact: David Carey212-867-1768
investors@eksobionics.com
Ekso Bionics (NASDAQ:EKSO)
Historical Stock Chart
From Mar 2024 to Apr 2024
Ekso Bionics (NASDAQ:EKSO)
Historical Stock Chart
From Apr 2023 to Apr 2024